Calcium and phosphate changes after renal transplantation

Journal of Nephrology

Volumn 23, Issue SUPPL.16, 2010, Pages

  Messa, Piergiorgio ^a   Cafforio, Cosimo ^a   Alfieri, Carlo ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Calcium phosphorus; Hyperparathyroidism; Renal transplant

Indexed keywords

CALCIUM; PHOSPHATE;

ANIMAL; HUMAN; HYPERCALCEMIA; HYPOPHOSPHATEMIA; KIDNEY TRANSPLANTATION; METABOLISM; REVIEW;

ANIMALS; CALCIUM; HUMANS; HYPERCALCEMIA; HYPOPHOSPHATEMIA; KIDNEY TRANSPLANTATION; PHOSPHATES;

EID: 79952278677     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Egbuna OI, Taylor JG, Bushinsky DA, Zand MS. Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure. Clin Transplant. 2007;21:558-566.
2. Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B, Vanrenterghem Y. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant. 2004;19:1281-1287.
3. Cundy T, Kanis JA, Heynen G, Morris PJ, Oliver DO. Calcium metabolism and hyperparathyroidism after renal transplantation. QJM. 1983;52:67-78.
4. Levi M. Post-transplant hypophosphatemia. Kidney Int. 2001;59:2377-2387.
5. Ramezani M, Einollahi B, Asl MA, et al. Calcium and phosphorus metabolism disturbances after renal transplantation. Transplant Proc. 2007;39:1033-1035.
6. Sprague SM, Belozeroff V, Danese MD, Martin LP, Olgaard K. Abnormal bone and mineral metabolism in kidney transplant patients: a review. Am J Nephrol. 2008;28:246-253.
7. Messa P, Sindici C, Cannella G, et al. Persistent secondary hyperparathyroidism after renal transplantation. Kidney Int. 1998;54:1704-1713.
8. Saha HH, Salmela KT, Ahonen PJ, et al. Sequential changes in vitamin D and calcium metabolism after successful renal transplantation. Scand J Urol Nephrol. 1994;28:21-7.
9. Stavroulopoulos A, Cassidy MJ, Porter CJ, Hosking DJ, Roe SD. Vitamin D status in renal transplant recipients. Am J Transplant. 2007;7:2546-2552.
10. Torres A, Lorenzo V, Salido E. Calcium metabolism and skeletal problems after transplantation. J Am Soc Nephrol. 2002;13:551-558.
11. Schankel K, Robinson J, Bloom RD, et al. Determinants of coronary artery calcification progression in renal transplant recipients. Am J Transplant. 2007;7:2158-2164.
12. Mazzaferro S, Pasquali M, Taggi F, et al. Progression of coronary artery calcification in renal transplantation and the role of secondary hyperparathyroidism and inflammation. Clin J Am Soc Nephrol. 2009;4:685-690.
13. Wu MS, Hung CC, Chang CT. Renal calcium handling after rapamycin conversion in chronic allograft dysfunction. Transpl Int. 2006;19:140-145.
14. Rosenbaum RW, Hruska KA, Korkor A, et al. Decreased phosphate reabsorption after renal transplantation: evidence for a mechanism independent of calcium and parathyroid hormone. Kidney Int. 1981;19:568-578.
15. Bhan I, Shah A, Holmes J, et al. Post-transplant hypophosphatemia: tertiary 'hyper-phosphatoninism'? Kidney Int. 2006;70:1486-1494.
16. Evenepoel P, Naesens M, Claes K, Kuypers D, Vanrenterghem Y. Tertiary 'hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients. Am J Transplant. 2007;7:1-8.
17. Ambühl PM. Posttransplant metabolic acidosis: a neglected factor in renal transplantation? Curr Opin Nephrol Hypertens. 2007;16:379-387.
18. Wrong O. Nephrocalcinosis, In: Davidsen AM, Cameron JS, Grunfeld JP, eds. Oxford textbook of clinical nephrology. Oxford: Oxford University Press; 1998:1375-1396.
19. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med. 2003;349:2326-2333.
20. Boom H, Mallat MJ, De Fijter JW, Paul LC, Bruijn JA, Van Es LA. Calcium levels as a risk factor for delayed graft function. Transplantation. 2004;77:868-873.
21. Gwinner W, Suppa S, Mengel M, et al. Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications. Am J Transplant. 2005;5:1934-1941.
22. Pinheiro HS, Câmara NO, Osaki KS, De Moura LA, Pacheco-Silva A. Early presence of calcium oxalate deposition in kidney graft biopsies is associated with poor longterm graft survival. Am J Transplant. 2005;5:323-329.
23. Evenepoel P, Lerut E, Naesens M, et al. Localization, etiology and impact of calcium phosphate deposits in renal allografts. Am J Transplant. 2009;9:2470-2478.
24. Habbig S, Beck BB, Feldkötter M, et al. Renal allograft calcification: prevalence and etiology in pediatric patients. Am J Nephrol. 2009;30:194-200.
25. O'Rourke B. The ins and outs of calcium in heart failure. Circ Res. 2008;102:1301-1303.
26. Dayanithi G, Viero C, Shibuya I. The role of calcium in the action and release of vasopressin and oxytocin from CNS neurones/terminals to the heart. J Physiol Pharmacol. 2008;59(Suppl 8):7-26.
27. Gusev K, Domenighetti AA, Delbridge LM, Pedrazzini T, Niggli E, Egger M. Angiotensin II-mediated adaptive and maladaptive remodeling of cardiomyocyte excitation-contraction coupling. Circ Res. 2009;105:42-50.
28. Nguyen PT, Coche E, Goffin E, et al. Prevalence and determinants of coronary and aortic calcifications assessed by chest CT in renal transplant recipients. Am J Nephrol. 2007;27:329-335.
29. Bubenicek P, Kautznerova D, Sotornik I, Adamec M, Lanska V, Teplan V. Coronary calcium score in renal transplant recipients. Nephron Clin Pract. 2009;112:c1-c8.
30. Kurella M, Butterly DW, Smith SR. Post transplant erythrocytosis in hypercalcemic renal transplant recipients. Am J Transplant. 2003;3:873-877.
31. Frick TW, Fryd DS, Sutherland DE, Goodale RL, Simmons RL, Najarian JS. Hypercalcemia associated with pancreatitis and hyperamylasemia in renal transplant recipients: data from the Minnesota randomized trial of cyclosporine versus antilymphoblast azathioprine. Am J Surg. 1987;154:487-489.
32. Brunelli SM, Goldfarb S. Hypophosphatemia: clinical consequences and management. J Am Soc Nephrol. 2007;18:1999-2003.
33. Rojas E, Carlini RG, Clesca P, et al. The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling. Kidney Int. 2003;63:1915-1923.
34. Evenepoel P, Claes K, Kuypers D, Maes B, Vanrenterghem Y. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study. Nephrol Dial Transplant. 2005;20:1714-1720.
35. Schwarz A, Rustien G, Merkel S, Radermacher J, Haller H. Decreased renal transplant function after parathyroidectomy. Nephrol Dial Transplant. 2007;22:584-591.
36. Evenepoel P, Claes K, Kuypers DR, Debruyne F, Vanrenterghem Y. Parathyroidectomy after successful kidney transplantation: a single centre study. Nephrol Dial Transplant. 2007;22:1730-1737.
37. Bonarek H, Merville P, Bonarek M, et al. Reduced parathyroid functional mass after successful kidney transplantation. Kidney Int. 1999;56:642-649.
38. Taniguchi M, Tokumoto M, Matsuo D, et al. Persistent hyperparathyroidism in renal allograft recipients: vitamin D receptor, calcium-sensing receptor, and apoptosis. Kidney Int. 2006;70:363-370.
39. Meola M, Petrucci I, Barsotti G. Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism. Nephrol Dial Transplant. 2009;24:982-989.
40. Serra AL, Schwarz AA, Wick FH, Marti HP, Wüthrich RP. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant. 2005;20:1315-1319.
41. Szwarc I, Argilés A, Garrigue V, et al. Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism. Transplantation. 2006;82:675-680.
42. Kruse AE, Eisenberger U, Frey FJ, Mohaupt MG. Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant. 2007;22:2362-2365.
43. Borchhardt KA, Heinzl H, Mayerwöger E, Hörl WH, Haas M, Sunder-Plassmann G. Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation. Transplantation. 2008;86:919-924.
44. Peng LW, Logan JL, James SH, Scott KM, Lien YH. Cinacalcet- associated graft dysfunction and nephrocalcinosis in a kidney transplant recipient. Am J Med. 2007;120:e7-e9.
45. Falck P, Vethe NT, Asberg A, et al. Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients. Nephrol Dial Transplant. 2008;23:1048-1053.
46. Falck P, Vethe NT, Asberg A, et al. Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients. Nephrol Dial Transplant. 2008;23:1048-1053.
47. Morales E, Gutierrez E, Andres A. Treatment with calcimimetics in kidney transplantation. Transplant Rev. 2010;24:79-88.
48. Ferrari SL, Bonjour JP, Rizzoli R. Fibroblast growth factor- 23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab. 2005;90:1519-1524.
49. Finch JL, Tokumoto M, Nakamura H, et al. The effect of paricalcitol and cinacalcet on serum phosphate, FGF-23 and bone in rats with chronic kidney disease. Am J Physiol Renal Physiol. 2010 Mar 3. [Epub ahead of print].
50. Ba J, Brown D, Friedman PA. Calcium-sensing receptor regulation of PTH-inhibitable proximal tubule phosphate transport. Am J Physiol Renal Physiol. 2003;285:F1233-F1243.
51. Serra AL, Wuhrmann C, Wütrich RP. Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism. Am J Kidney Dis. 2008;52:1151-1157.